Prevalence of trachoma at sub-district level in ethiopia: determining when to stop mass azithromycin distribution.
<h4>Background</h4>To eliminate blinding trachoma, the World Health Organization emphasizes implementing the SAFE strategy, which includes annual mass drug administration (MDA) with azithromycin to the whole population of endemic districts. Prevalence surveys to assess impact at the dist...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bb9e6d262df1489bb459573c5d76dc5b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:bb9e6d262df1489bb459573c5d76dc5b |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:bb9e6d262df1489bb459573c5d76dc5b2021-11-18T09:16:19ZPrevalence of trachoma at sub-district level in ethiopia: determining when to stop mass azithromycin distribution.1935-27271935-273510.1371/journal.pntd.0002732https://doaj.org/article/bb9e6d262df1489bb459573c5d76dc5b2014-03-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24625539/pdf/?tool=EBIhttps://doaj.org/toc/1935-2727https://doaj.org/toc/1935-2735<h4>Background</h4>To eliminate blinding trachoma, the World Health Organization emphasizes implementing the SAFE strategy, which includes annual mass drug administration (MDA) with azithromycin to the whole population of endemic districts. Prevalence surveys to assess impact at the district level are recommended after at least 3 years of intervention. The decision to stop MDA is based on a prevalence of trachomatous inflammation follicular (TF) among children aged 1-9 years below 5% at the sub-district level, as determined by an additional round of surveys limited within districts where TF prevalence is below 10%. We conducted impact surveys powered to estimate prevalence simultaneously at the sub-district and district in two zones of Amhara, Ethiopia to determine whether MDA could be stopped.<h4>Methodology</h4>Seventy-two separate population-based, sub-district surveys were conducted in 25 districts. In each survey all residents from 10 randomly selected clusters were screened for clinical signs of trachoma. Data were weighted according to selection probabilities and adjusted for correlation due to clustering.<h4>Principal findings</h4>Overall, 89,735 residents were registered from 21,327 households of whom 72,452 people (80.7%) were examined. The prevalence of TF in children aged 1-9 years was below 5% in six sub-districts and two districts. Sub-district level prevalence of TF in children aged 1-9 years ranged from 0.9-76.9% and district-level from 0.9-67.0%. In only one district was the prevalence of trichiasis below 0.1%.<h4>Conclusions/significance</h4>The experience from these zones in Ethiopia demonstrates that impact assessments designed to give a prevalence estimate of TF at sub-district level are possible, although the scale of the work was challenging. Given the assessed district-level prevalence of TF, sub-district-level surveys would have been warranted in only five districts. Interpretation was not as simple as stopping MDA in sub-districts below 5% given programmatic challenges of exempting sub-districts from a highly regarded program and the proximity of hyper-endemic sub-districts.Jonathan D KingTesfaye TeferiElizabeth A CromwellMulat ZerihunJeremiah M NgondiMesele DamteFrew AyalewZerihun TadesseTeshome GebreAyelign MulualemAlemu KarieBerhanu MelakMitku AdugnaDemelash GessesseAbebe WorkuTekola EndashawFisseha Admassu AyeleNicole E StollerMary Rose A KingAryc W MosherTesfaye GebregzabherGeremew HaileysusPeter OdermattJürg UtzingerPaul M EmersonPublic Library of Science (PLoS)articleArctic medicine. Tropical medicineRC955-962Public aspects of medicineRA1-1270ENPLoS Neglected Tropical Diseases, Vol 8, Iss 3, p e2732 (2014) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 |
spellingShingle |
Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 Jonathan D King Tesfaye Teferi Elizabeth A Cromwell Mulat Zerihun Jeremiah M Ngondi Mesele Damte Frew Ayalew Zerihun Tadesse Teshome Gebre Ayelign Mulualem Alemu Karie Berhanu Melak Mitku Adugna Demelash Gessesse Abebe Worku Tekola Endashaw Fisseha Admassu Ayele Nicole E Stoller Mary Rose A King Aryc W Mosher Tesfaye Gebregzabher Geremew Haileysus Peter Odermatt Jürg Utzinger Paul M Emerson Prevalence of trachoma at sub-district level in ethiopia: determining when to stop mass azithromycin distribution. |
description |
<h4>Background</h4>To eliminate blinding trachoma, the World Health Organization emphasizes implementing the SAFE strategy, which includes annual mass drug administration (MDA) with azithromycin to the whole population of endemic districts. Prevalence surveys to assess impact at the district level are recommended after at least 3 years of intervention. The decision to stop MDA is based on a prevalence of trachomatous inflammation follicular (TF) among children aged 1-9 years below 5% at the sub-district level, as determined by an additional round of surveys limited within districts where TF prevalence is below 10%. We conducted impact surveys powered to estimate prevalence simultaneously at the sub-district and district in two zones of Amhara, Ethiopia to determine whether MDA could be stopped.<h4>Methodology</h4>Seventy-two separate population-based, sub-district surveys were conducted in 25 districts. In each survey all residents from 10 randomly selected clusters were screened for clinical signs of trachoma. Data were weighted according to selection probabilities and adjusted for correlation due to clustering.<h4>Principal findings</h4>Overall, 89,735 residents were registered from 21,327 households of whom 72,452 people (80.7%) were examined. The prevalence of TF in children aged 1-9 years was below 5% in six sub-districts and two districts. Sub-district level prevalence of TF in children aged 1-9 years ranged from 0.9-76.9% and district-level from 0.9-67.0%. In only one district was the prevalence of trichiasis below 0.1%.<h4>Conclusions/significance</h4>The experience from these zones in Ethiopia demonstrates that impact assessments designed to give a prevalence estimate of TF at sub-district level are possible, although the scale of the work was challenging. Given the assessed district-level prevalence of TF, sub-district-level surveys would have been warranted in only five districts. Interpretation was not as simple as stopping MDA in sub-districts below 5% given programmatic challenges of exempting sub-districts from a highly regarded program and the proximity of hyper-endemic sub-districts. |
format |
article |
author |
Jonathan D King Tesfaye Teferi Elizabeth A Cromwell Mulat Zerihun Jeremiah M Ngondi Mesele Damte Frew Ayalew Zerihun Tadesse Teshome Gebre Ayelign Mulualem Alemu Karie Berhanu Melak Mitku Adugna Demelash Gessesse Abebe Worku Tekola Endashaw Fisseha Admassu Ayele Nicole E Stoller Mary Rose A King Aryc W Mosher Tesfaye Gebregzabher Geremew Haileysus Peter Odermatt Jürg Utzinger Paul M Emerson |
author_facet |
Jonathan D King Tesfaye Teferi Elizabeth A Cromwell Mulat Zerihun Jeremiah M Ngondi Mesele Damte Frew Ayalew Zerihun Tadesse Teshome Gebre Ayelign Mulualem Alemu Karie Berhanu Melak Mitku Adugna Demelash Gessesse Abebe Worku Tekola Endashaw Fisseha Admassu Ayele Nicole E Stoller Mary Rose A King Aryc W Mosher Tesfaye Gebregzabher Geremew Haileysus Peter Odermatt Jürg Utzinger Paul M Emerson |
author_sort |
Jonathan D King |
title |
Prevalence of trachoma at sub-district level in ethiopia: determining when to stop mass azithromycin distribution. |
title_short |
Prevalence of trachoma at sub-district level in ethiopia: determining when to stop mass azithromycin distribution. |
title_full |
Prevalence of trachoma at sub-district level in ethiopia: determining when to stop mass azithromycin distribution. |
title_fullStr |
Prevalence of trachoma at sub-district level in ethiopia: determining when to stop mass azithromycin distribution. |
title_full_unstemmed |
Prevalence of trachoma at sub-district level in ethiopia: determining when to stop mass azithromycin distribution. |
title_sort |
prevalence of trachoma at sub-district level in ethiopia: determining when to stop mass azithromycin distribution. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2014 |
url |
https://doaj.org/article/bb9e6d262df1489bb459573c5d76dc5b |
work_keys_str_mv |
AT jonathandking prevalenceoftrachomaatsubdistrictlevelinethiopiadeterminingwhentostopmassazithromycindistribution AT tesfayeteferi prevalenceoftrachomaatsubdistrictlevelinethiopiadeterminingwhentostopmassazithromycindistribution AT elizabethacromwell prevalenceoftrachomaatsubdistrictlevelinethiopiadeterminingwhentostopmassazithromycindistribution AT mulatzerihun prevalenceoftrachomaatsubdistrictlevelinethiopiadeterminingwhentostopmassazithromycindistribution AT jeremiahmngondi prevalenceoftrachomaatsubdistrictlevelinethiopiadeterminingwhentostopmassazithromycindistribution AT meseledamte prevalenceoftrachomaatsubdistrictlevelinethiopiadeterminingwhentostopmassazithromycindistribution AT frewayalew prevalenceoftrachomaatsubdistrictlevelinethiopiadeterminingwhentostopmassazithromycindistribution AT zerihuntadesse prevalenceoftrachomaatsubdistrictlevelinethiopiadeterminingwhentostopmassazithromycindistribution AT teshomegebre prevalenceoftrachomaatsubdistrictlevelinethiopiadeterminingwhentostopmassazithromycindistribution AT ayelignmulualem prevalenceoftrachomaatsubdistrictlevelinethiopiadeterminingwhentostopmassazithromycindistribution AT alemukarie prevalenceoftrachomaatsubdistrictlevelinethiopiadeterminingwhentostopmassazithromycindistribution AT berhanumelak prevalenceoftrachomaatsubdistrictlevelinethiopiadeterminingwhentostopmassazithromycindistribution AT mitkuadugna prevalenceoftrachomaatsubdistrictlevelinethiopiadeterminingwhentostopmassazithromycindistribution AT demelashgessesse prevalenceoftrachomaatsubdistrictlevelinethiopiadeterminingwhentostopmassazithromycindistribution AT abebeworku prevalenceoftrachomaatsubdistrictlevelinethiopiadeterminingwhentostopmassazithromycindistribution AT tekolaendashaw prevalenceoftrachomaatsubdistrictlevelinethiopiadeterminingwhentostopmassazithromycindistribution AT fissehaadmassuayele prevalenceoftrachomaatsubdistrictlevelinethiopiadeterminingwhentostopmassazithromycindistribution AT nicoleestoller prevalenceoftrachomaatsubdistrictlevelinethiopiadeterminingwhentostopmassazithromycindistribution AT maryroseaking prevalenceoftrachomaatsubdistrictlevelinethiopiadeterminingwhentostopmassazithromycindistribution AT arycwmosher prevalenceoftrachomaatsubdistrictlevelinethiopiadeterminingwhentostopmassazithromycindistribution AT tesfayegebregzabher prevalenceoftrachomaatsubdistrictlevelinethiopiadeterminingwhentostopmassazithromycindistribution AT geremewhaileysus prevalenceoftrachomaatsubdistrictlevelinethiopiadeterminingwhentostopmassazithromycindistribution AT peterodermatt prevalenceoftrachomaatsubdistrictlevelinethiopiadeterminingwhentostopmassazithromycindistribution AT jurgutzinger prevalenceoftrachomaatsubdistrictlevelinethiopiadeterminingwhentostopmassazithromycindistribution AT paulmemerson prevalenceoftrachomaatsubdistrictlevelinethiopiadeterminingwhentostopmassazithromycindistribution |
_version_ |
1718420925288808448 |